http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-20090100483-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e4de608e00ae4c35e3421e0ade664ef |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-00 |
| filingDate | 2009-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b79325363fd12d068af9a076fa95bcfe |
| publicationDate | 2011-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GR-20090100483-A |
| titleOfInvention | A NON-STEARULU AND N-PALMITOUL DOPAMIDIAN ACTION SYSTEM |
| abstract | The invention relates to the anticancer use (monotherapy or in combination with clinically used anticancer drugs) of N-stearoil (S-DA) and N-palmitoyl dopamide (P-DA), on all cancer cell lines. The invention mainly relates to their use as synergistic drugs with the main anticancer drugs: paclitaxel, oxaIipIatia, vincristine, which cause severe neuropathic pain. Indeed, S-DA and P-DA increase the effectiveness of the above anticancer drugs, and compete with the setting and extent of neuropathic pain. |
| priorityDate | 2009-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.